Literature DB >> 22134745

Gene transfer using HACs: a key step closer to ex vivo gene therapy using autologous gene-corrected cells to treat muscular dystrophy.

Jacques P Tremblay1, Robert M Frederickson.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22134745      PMCID： PMC3242673          DOI： 10.1038/mt.2011.254

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  9 in total

Review 1.  Human artificial chromosomes for gene delivery and the development of animal models.

Authors:  Yasuhiro Kazuki; Mitsuo Oshimura
Journal:  Mol Ther       Date:  2011-07-12       Impact factor: 11.454

2.  Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cells.

Authors:  Daniel Skuk; Martin Paradis; Marlyne Goulet; Pierre Chapdelaine; David M Rothstein; Jacques P Tremblay
Journal:  Mol Ther       Date:  2010-07-06       Impact factor: 11.454

Review 3.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

Review 4.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

Review 5.  Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.

Authors:  Annemieke Aartsma-Rus; Ivo Fokkema; Jan Verschuuren; Ieke Ginjaar; Judith van Deutekom; Gert-Jan van Ommen; Johan T den Dunnen
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

6.  Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy.

Authors:  Francesco Saverio Tedesco; Hidetoshi Hoshiya; Giuseppe D'Antona; Mattia F M Gerli; Graziella Messina; Stefania Antonini; Rossana Tonlorenzi; Sara Benedetti; Libera Berghella; Yvan Torrente; Yasuhiro Kazuki; Roberto Bottinelli; Mitsuo Oshimura; Giulio Cossu
Journal:  Sci Transl Med       Date:  2011-08-17       Impact factor: 17.956

7.  Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs.

Authors:  Maurilio Sampaolesi; Stephane Blot; Giuseppe D'Antona; Nicolas Granger; Rossana Tonlorenzi; Anna Innocenzi; Paolo Mognol; Jean-Lauren Thibaud; Beatriz G Galvez; Ines Barthélémy; Laura Perani; Sara Mantero; Maria Guttinger; Orietta Pansarasa; Chiara Rinaldi; M Gabriella Cusella De Angelis; Yvan Torrente; Claudio Bordignon; Roberto Bottinelli; Giulio Cossu
Journal:  Nature       Date:  2006-11-15       Impact factor: 49.962

8.  Human artificial chromosome with a conditional centromere for gene delivery and gene expression.

Authors:  Yuichi Iida; Jung-Hyun Kim; Yasuhiro Kazuki; Hidetoshi Hoshiya; Masato Takiguchi; Masahiro Hayashi; Indri Erliandri; Hee-Sheung Lee; Alex Samoshkin; Hiroshi Masumoto; William C Earnshaw; Natalay Kouprina; Vladimir Larionov; Mitsuo Oshimura
Journal:  DNA Res       Date:  2010-08-26       Impact factor: 4.458

9.  Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts.

Authors:  Maurilio Sampaolesi; Yvan Torrente; Anna Innocenzi; Rossana Tonlorenzi; Giuseppe D'Antona; M Antonietta Pellegrino; Rita Barresi; Nereo Bresolin; M Gabriella Cusella De Angelis; Kevin P Campbell; Roberto Bottinelli; Giulio Cossu
Journal:  Science       Date:  2003-07-10       Impact factor: 47.728
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.